Clinical Trial Update: Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of oral famciclovir for active recurrent genital herpes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes

Drugs mentioned

• Famciclovir (Famvir) (famciclovir)

Snippet

Sponsor: Novartis | Conditions: Recurrent Genital Herpes | Phase 3 | Status: COMPLETED